Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. [electronic resource]
Producer: 20131126Description: 273 p. digitalISSN:- 1471-2407
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Autocrine Communication -- drug effects
- Blotting, Western
- Breast Neoplasms -- metabolism
- Celecoxib
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Female
- Humans
- Mice
- Neovascularization, Pathologic -- chemically induced
- Pyrazoles -- administration & dosage
- Reactive Oxygen Species -- metabolism
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Sulfonamides -- administration & dosage
- Tamoxifen -- administration & dosage
- Transfection
- Vascular Endothelial Growth Factor A -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.